Advanced search
Publication Cover
Acta Cardiologica Volume 59, 2004 - Issue 6
Submit an article Journal homepage
8
Views
0
CrossRef citations to date
0
Altmetric
Articles

The eNOS gene polymorphism does not have a major impact on lipid parameters and premature coronary artery disease in Caucasian women

Mitja LetonjaDepartment of Internal Medicine, General Hospital Ptuj, Slovenia.Correspondence[email protected]
Pages 618-622 | Received 27 Nov 2003, Accepted 24 May 2004, Published online: 23 May 2017

References

  • Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiol-ogy, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109–42.
  • Wang Y, Mardsen PA. Nitric oxide synthases: biochemical and molecular regulation. Curr Opin Nephrol Hypertens 1995; 4: 12–22.
  • Valiance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; 2: 997–1000.
  • Quyyumi AA, Dakak N, Andrevs NP, Husian S, Arora S, Gilligan DM, Panza JA, Canon RO III. Nitric oxide activ-ity in human coronary circulation. J Clin Invest 1995; 95: 1747–55.
  • Yao S-K, Ober JC, Krishnaswami A, Ferguson JJ, Ander-son V, Golino P, Buja LM, Willerson JT. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. Cir-culation 1992; 86: 1302–9.
  • Kubes P, Suzuki M, Granger DN. Nitric oxide: an endoge-nous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88: 4651–5.
  • Garg UC, Hassid A. Nitric oxide-generating vasodilatators and 8-bromocycic guanosine monophosphate inhibit mito-genesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83: 1774–7.
  • Hogg N, Kalyaraman B, Joseph J, Struck A, Parthasarathy S. Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis. FEBS Lett 1993; 334: 170–4.
  • Mardsen PA, Heng HH, Scherer SW. Structure and chro-mosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 1993; 268: 17478–88.
  • Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DEL. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nature Med 1996; 2: 41–5.
  • Hibi K, Isigami T, Tamura K, Shunsaku M, Nyui N, Fujita T, Umemura S. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hyperten-sion 1998; 32: 521–62.
  • Hooper WC, Lally C, Austin H, Benson J, Dilley A, Wenger NK, Whitsett C, Rawlins P, Evatt BL. The rela-tionship between polymorphism in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African Americans. Chest 1999; 116: 880–6.
  • Sigusch HH, Surber R, Lehmann MH, Surber S, Weber J, Henke A, Reinhardt D, Hoffman A, Figulla HR. Lack of association between 27-bp repeat polymorphism in intron 4 of the endothelial nitric oxide synthase gene and the risk of coronary artery disease. Scan J Clin Lab Invest 2000; 60: 229–35.
  • Petrovic D, Zorc M, Peterlin B. Effect of apolipoprotein E polymorphism and apolipoprotein A-1 gene promoter poly-morphism on lipid parameters and premature coronary artery disease. Folia Biol (Praha) 2000; 46: 181–5.
  • Petrovic D, Peterlin B. Estrogen receptor dinucleotide (TA) polymorphism does not predict premature myocardial infarction in Caucasian women. Cardiology 2003; 99: 163–5.
  • Ichiara S, Yamada Y, Fujimara T, Nakashima N, Yokota M. Association of a polymorphism of endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population. Am J Cardiol 1998; 81: 83–6.
  • Cine N, Hatemi AC, Erginel-Unaltuna N. Association of a polymorphism of the ecNOS gene with myocardial infarc-tion in a subgroup of Turkish MI patients. Clin Genet 2002; 61: 66–70.
  • Via M, Lopez-Alomar A, Valveny N, Gonzalez-Perez, Pedro M. Lack of association between eNOS gene poly-morphism and ischemic heart disease in the Spanish popu-lation. Am J Med Gen 2003; 116A: 243–8.
  • Yoon Y, Song J, Hong HS, Kim JQ. Plasma nitric oxide con-centrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin Chem 2000; 46: 1626–30.
  • Pulkkinen A, Viitanen L, Kareinen A, Lehto S, Vauhko-nen I, Laakso M. Intron 4 polymorphism of the endothe-lial nitric oxide synthase gene is associated with elevated blood pressure in type 2 diabetic patients with coronary heart disease. J Mol Med 2000; 78: 372–9.
  • Gardermann A, Lohre J, Cayci S, Katz N, Tillmanns H, Haberbosh W The T allele of the missense Glu298Asp endothelial nitric oxide synthase gene polymorphism is asso-ciated with coronary heart disease in younger individuals with high atherosclerotic profile. Atherosclerosis 2002; 160: 167–75.
  • Fowkes FG, Lee AJ, Hau CM, Cooke A, Connor JM, Lowe GD. Methylene tetrahydrofolate reductase (MTHFR) and nitric oxide synthase (ecNOS) genes and risks of periph-eral arterial disease and coronary heart disease: Edinburgh Artery Study. Atherosclerosis 2000; 150; 179–85.
  • Granath B, Taylor RR, Bockxmeer FM van, Mamotte CD. Lack of evidence for association between endothelial nitric oxide synthase gene polymorphisms and coronary artery dis-ease in Australian Caucasian population. J Cardiovasc Risk 2001; 8: 235–41.
  • Tsukada T, Yokoyama K, Arai T, Takemoto F, Hara S, Yamada A, Kawaguchi Y, Hosoya T, Igari J. Evidence of association of ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun 1998; 245: 190–3.
  • Wang XL, Mahaney MC, Sim AS, Wang J, Blancero J, Almasy L, Badenhop RB, Wilcken DE. Genetic contribution of the nitric oxide synthase gene to plasma nitric oxide level. Atheroscler Thromb Vasc Biol 1997; 17: 3147–53.
  • Petrovic D, Zorc M, Kanic V, Peterlin B. Interaction between gene polymorphisms of renin-angiotensin system andmetabolic risk factors in premature myocardial infarction. Angiology 2001; 52: 247–52.
  • Petrovic D, Globocnik-Petrovic M, Peterlin B. 4G4G geno-type of PAT-1 gene promoter polymorphism is not associated with myocardial infarction in Caucasians with type-2 dia-betes. Cardiology 2003; 100: 157–8.
  • Petrovic D, Zorc M, Keber I, Peterlin B. Joint effect of G1691A factor V point mutation and factor VII Arg/G1n(353) gene polymorphism on the risk of premature coronary artery disease. Ann Genet 2001; 44: 33–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.